  
     
      
 |
|
| |
We are focused on:
 |
Increasing revenue growth by targeting the dynamic life-science
market, expanding our service offering to the pharmaceutical
industry, and pursuing additional opportunities in homeland
security. |
|
Improving profit margins by achieving a higher concentration
of proprietary products, consolidating facilities and
leveraging information systems. |
|
Continuing to optimize working capital to improve return
on capital. |
|
Using increased cash flow to fund acquisition growth
and reduce outstanding debt. |
|
|
|
PAGE 1 of 6